can semaglutide make your heart race and rate: Understanding the risks Semaglutide and the Heart: Focus

Clinicians should consider individual patient factors and monitor for changes, especially in those with existing arrhythmias

What Is Semaglutide (GLP-1) Therapy

Essential versus accessory aspects of cell death: recommendations of the NCCD 2015

[1] [2] [12] The best supporting evidence is indirect: in STEP 4 and SURMOUNT-4, people who stopped these medications regained most of their lost weight, while people who continued kept their results

The growing prevalence of metabolic disease, CKD, and ASCVD have prompted investigation into the role of GLP-1R agonists in mitigating cardiovascular and metabolic risks, particularly within the framework of Cardiovascular-Kidney-Metabolic (CKM) Syndrome, irrespective of diabetic status

It is not a primary investigation and should be performed only when the diagnosis has not been achieved by history, barium radiology or endoscopy